Teva Pharmaceuticals to Buy Allergan's Generics Business - The New York Times
Teva deal lets us double down on brands: Allergan CEO
Teva to Buy Anda from Allergan | CHEManager
/arc-anglerfish-arc2-prod-pmn.s3.amazonaws.com/public/LCGCPK3EYBF3PJZYOYFN26JDWQ.jpg "Teva buying Allergan, drops Mylan bid")
Teva buying Allergan, drops Mylan bid
Purchase of Allergan and Sale of Teva - Vitaliy Katsenelson Contrarian Edge
Teva to buy Allergan generic business for $40.5 billion, drops Mylan bid | Reuters
Teva buys Allergan's generic drug unit for $40.5B
Settling a post-buyout hangover, Allergan gives Teva a $700M remedy | Fierce Pharma
Teva deal lets us double down on brands: Allergan CEO
Allergan steps away from generics with sale to Teva | Business | Chemistry World
Teva wants Allergan's distribution biz now that $40B drug deal has closed | Fierce Pharma
Allergan sells generic drug unit to Israel's Teva for $40.5 billion - Los Angeles Times
Teva to Divest 79 Generic Drugs to Settle FTC Concerns With Allergan Generics Acquisition | RAPS
Teva drops bid for Mylan, buys Allergan's generic drug unit - Philadelphia Business Journal
Allergan to sell a quarter of its Teva stake in first quarter of 2018 | Reuters
Teva's Multibillion-Dollar Purchase of Allergan Approved
Teva Pharmaceuticals to Buy Allergan's Generics Business - The New York Times
Teva completes $40b purchase of Allergan generics arm | The Times of Israel
Teva to Buy Allergan Generics for $40.5 Billion - WSJ
Teva agrees to buy Allergan's generics distribution unit
A Timeline Of Teva's M&A Over The Past Year
Teva buys Allergan: 3 reasons why it's a blockbuster deal | Fortune
/cloudfront-us-east-1.images.arcpublishing.com/gray/NTZZMVWJCVHFXDGT7B7G5ZMBKQ.jpg "Attorney General Stein announces settlement finalization with Teva Pharmaceuticals and Allergan, over $180 million to go to North Carolina")
Attorney General Stein announces settlement finalization with Teva Pharmaceuticals and Allergan, over $180 million to go to North Carolina
AG Reaches $33.3M Agreement with Teva, Allergan; Opioid Makers Agree to Restrictions on Sales, Marketing - InDepthNH.orgInDepthNH.org
